Challenges Facing Providers Caring for HIV/HCV-Coinfected Patients

Abstract

Despite the high prevalence of hepatitis C virus (HCV) infection among injection drug users also infected with human immunodeficiency virus (HIV), and the synergistic adverse effect of the two diseases on patients’ health and survival, research on the clinical management of these patients and particularly the low uptake of HCV therapy is limited. We conducted qualitative interviews with 17 HIV providers from two urban public hospitals. We discovered that the limitations of the current state of medical knowledge, the severe side effects of HIV and HCV therapies, and the psychosocial vulnerability of HIV/HCV-coinfected patients combined with their resistance to becoming informed about HCV posed significant challenges for providers. To contend with these challenges, providers incorporated key dimensions of patient-centered medicine in their practice, such as considering their patients’ psychosocial profiles and the meaning patients assign to being coinfected, and finding ways to engage their patients in a therapeutic alliance.

Keywords

health care health care professionals hepatitis C HIV/AIDS marginalized populations

Get full access to this article

View all access options for this article.

References

Adeyemi

O. M.

Jensen

Attar

Ghaoui

Gallagher

Wolen

Cotler

S. J.

(2004). Hepatitis C treatment eligibility in an urban population with and without HIV coinfection. AIDS Patient Care and STDs, 18, 239-245. doi:10.1089/10872910432303891910.1089/108729104323038919.

Balint

(1969). The possibilities of patient-centered medicine. Journal of the Royal College of General Practitioners, 17, 269-276.

Bova

Ogawa

L. F.

Sullivan-Bolyai

(2010). Hepatitis C treatment experiences and decision making among patients living with HIV infection. Journal of the Association of Nurses in AIDS Care, 21, 63-74. doi:10.1016/j.jana.2009.07./00910.1016/j.jana.2009.07./009

Centers for Disease Control and Prevention. (2004). Treating opportunistic infections among HIV-infected adults and adolescents: Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. Morbidity and Mortality Weekly Report, 53(No. RR-15), 51-53. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5315a1.htm

Clanon

K. A.

Mueller

J. J.

Harank

(2005). Integrating treatment for hepatitis C virus infection into an HIV clinic. Clinical Infectious Diseases, 40, S362-S366. doi:10.1086/42745410.1086/427454

Corcoran

C. P.

(2003). Neuropsychiatric changes in HIV/hepatitis C coinfected patients undergoing interferon therapy. Journal of the Association of Nurses in AIDS Care, 14, 80S-86S. doi:10.1177/105532900325558910.1177/1055329003255589

Dore

G. J.

Thomas

D. L.

(2005). Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection. Seminars in Liver Disease, 25, 18-32. doi:10.1055/s-2005-86477910.1055/s-2005-864779

Fleming

C. A.

Tumilty

Murray

J. E.

Nunes

(2005). Challenges in the treatment of patients coinfected with HIV and hepatitis C virus: Need for team care. Clinical Infectious Diseases, 40, S349-S354. doi:10.1086/42745210.1086/427452

Fuller

B. E.

Loftis

J. M.

Rodriguez

V. L.

McQuesten

M. J.

Hauser

(2009). Psychiatric and substance use disorders comorbidities in veterans with hepatitis C virus and HIV coinfection. Current Opinion in Psychiatry, 22, 401-408. doi:10.1097/YCO.0b013e32832cadb910.1097/YCO.0b013e32832cadb9

10.

Fultz

S. L.

Justice

A. C.

Butt

A. A.

Rabeneck

Weissman

Rodriguez-Barradas

(2003). Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with human immunodeficiency virus infection. Clinical Infectious Diseases, 36, 1039-1046. doi:10.1086/37404910.1086/374049

11.

Grebely

Genoway

K. A.

Raffa

J. D.

Dhadwal

Rajan

Showler

Fischer

(2008). Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. Drug and Alcohol Dependence, 93, 141-147. doi:10.1016/j.drugalcdep.2007.09.00810.1016/j.drugalcdep.2007.09.008

12.

Keirns

C. C.

Dorr Goold

(2009). Patient-centered care and preference-sensitive decision making. JAMA, 302, 1805-1806. doi:10.1001/jama.2009.155010.1001/jama.2009.1550

13.

Laine

Davidoff

(1996). Patient-centered medicine: A professional evolution. JAMA, 275, 152-156. doi:10.1001/jama.1996.0353026006603510.1001/jama.1996.03530260066035

14.

Marcellin

Preau

Dellamonica

Ravaux

Kurkdji

Protopoescu

Spire

(2007). Adding HCV treatment to HIV treatment in HIV-HCV coinfected patients: The impact on the different dimensions of fatigue and self-reported side effects. Journal of Pain and Symptom Management, 34, 413-421. doi:10.1016/j.jpainsymman.2006.12.01410.1016/j.jpainsymman.2006.12.014

15.

Mead

Bower

(2000). Patient-centredness: A conceptual framework and review of the empirical literature. Social Science and Medicine, 51, 1087-1110. doi:10.1016/S0277-9536(00)00098-810.1016/S0277-9536(00)00098-8

16.

Mehta

S. H.

Genberg

B. L.

Astemborski

Kavasery

Kirk

G. D.

Vlahov

Thomas

D. L.

(2008). Limited uptake of hepatitis C treatment among injection drug users. Journal of Community Health, 33, 126-133. doi:10.1007/s10900-007-9083-310.1007/s10900-007-9083-3

17.

Mehta

S. H.

Thomas

D. L.

Sulkowski

M. S.

Safaein

Vlahov

Strathdee

S. A.

(2005). A framework for understanding factors that affect access and utilization of treatment for hepatitis C virus infection among HCV-mono-infected and HIV/HCV-co-infected injection drug users. AIDS, 19(Suppl. 3), S179-S189.

18.

Morse

J. M.

(2009). The PI as participant. Qualitative Health Research, 19, 1655. doi:10.1177/104973230935342110.1177/1049732309353421

19.

Muhr

(1997). ATLAS.ti: The knowledge workbench short user’s manual. Berlin: Scientific Software Development.

20.

Nunes

Saitz

Libman

Cheng

D. M.

Vidaver

Samet

J. H.

(2006). Barriers to treatment of hepatitis C in HIV/HCV-coinfected adults with alcohol problems. Alcohol Clinical Experimental Research, 30, 1520-1526. doi:10.1111/j.1530-0277.2006.00183.x10.1111/j.1530-0277.2006.00183.x

21.

Silberbogen

A. K.

Ulloa

E. W.

Janke

E. A.

Mori

D. L.

(2009). Psychosocial issues and mental health treatment recommendations for patients with hepatitis C. Psychosomatics, 50, 114-122. doi:10.1176/appi.psy.50.2.11410.1176/appi.psy.50.2.114

22.

Soriano

Puoti

Sulkowski

Cargnel

Benhamou

Peters

Rockstroh

(2007). Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV international panel. AIDS, 21, 1073-1089. doi:10.1097/QAD.0b013e3281084e4d10.1097/QAD.0b013e3281084e4d

23.

Stewart

Brown

J. B.

Weston

W., W.

McWhinney

I. R.

McWilliam

C. L.

Freeman

T. R.

(2003). Patient-centered medicine: Transforming the clinical method (2nd ed.). Abingdon, UK: Radcliffe Medical Press.

24.

Strader

D. B.

Wright

Thomas

D. L.

Seeff

L. B.

(2004). Diagnosis, management, and treatment of hepatitis C. Hepatology, 39, 1147-1171. doi:10.1002/hep.2011910.1002/hep.20119

25.

Sulkowski

(2008a). Treatment of hepatitis C in HIV-infected persons: A work in progress. Journal of Hepatology, 48, 5-7. doi:10.1016/j.jhep.2007.10.00610.1016/j.jhep.2007.10.006

26.

Sulkowski

M. S.

(2008b). Viral hepatitis and HIV coinfection. Journal of Hepatology, 48, 353-367. doi:10.1016/j.jhep.2007.11.00910.1016/j.jhep.2007.11.009

27.

Thompson

V. V.

Ragland

K. E.

Hall

C. S.

Morgan

Bangsberg

D. R.

(2005). Provider assessment of eligibility for hepatitis C treatment in HIV-infected homeless and marginally housed persons. AIDS, 19(Suppl. 3), S208-S214.

28.

Wagner

Ryan

Osilla

K. C.

Bhatti

Goetz

Witt

(2009). Treat early or wait and monitor? A qualitative analysis of provider hepatitis C virus treatment decision-making in the context of HIV coinfection. AIDS Patient Care and STDs, 21, 715-725. doi:10.1089/apc.2009.004910.1089/apc.2009.0049

29.

Wagner

G. J.

Ryan

G. W.

(2005). Hepatitis C virus treatment decision-making in the context of HIV co-infection: The role of medical, behavioral and mental health factors in assessing treatment readiness. AIDS, 19(Suppl. 3), S190-S198.

30.

Weiss

J. J.

Gorman

J. M.

(2006). Psychiatric behavioral aspects of comanagement of hepatitis C virus and HIV. Current HIV/AIDS Reports, 3, 176-181. doi:10.1007/s11904-006-0013-210.1007/s11904-006-0013-2

31.

Weiss

J. J.

Morgello

(2009). Psychiatric management of HIV/HCV-coinfected patients beginning treatment for hepatitis C virus infection: Survey of provider practices. General Hospital Psychiatry, 3, 531-537. doi:10.1016/j.genhosppsych.2009.05.00610.1016/j.genhosppsych.2009.05.006